Biotechnology
Peptisystems Secures Growth Equity Investment From Rubicon Healthcare Partners To Accelerate Commercial Expansion
Share
UPPSALA, Sweden, Nov. 13, 2025 /PRNewswire/ -- PeptiSystems, a life science company developing advanced manufacturing solutions for peptide and oligonucleotide-based therapeutics, has announced a significant growth investment from Rubicon Healthcare Partners. The partnership will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions to a rapidly growing biopharma market.
Rubicon Healthcare Partners is a growth-oriented investment firm focused on Nordic life science companies supplying products, services, and technologies to the healthcare and biopharmaceutical industries. Through this partnership, Rubicon brings valuable experience and networks to support PeptiSystems' international expansion and strategic development. Rubicon will become the largest shareholder in PeptiSystems after the transaction.
The investment enables PeptiSystems to further accelerate its commercial development and strengthen the organization for the next phase of growth. Building on its expanding customer base and the commercial momentum, the company is now advancing toward large-scale industrial applications and supporting customers in the transition to GMP production of therapeutic peptides and oligonucleotides.
"We are pleased to welcome Rubicon Healthcare Partners as a new shareholder in PeptiSystems. Their global life science experience and Nordic presence will be a valuable asset as we take the next steps in driving commercialization and scale our technology for industrial applications. This investment reflects confidence in our team and our strategy to drive growth in a rapidly expanding market," says Karin Granath, CEO of PeptiSystems.
"We are proud to partner with PeptiSystems and support their robust growth strategy. The company's strong values, commitment to excellence, and strategic vision align nicely with our investment philosophy. We were attracted to PeptiSystems' innovative best-in-class instrument portfolio, customer-centric approach, and excellent management team," says Ole J. Dahlberg, Managing Partner at Rubicon Healthcare Partners.
"I welcome Rubicon as major shareholder in PeptiSystems. This financial injection will further speed up our growth ability in providing our unique flow through technology for the production of therapeutic peptides and oligos," says Mats Johnson, Chairman of the Board of PeptiSystems.
The transaction is subject to customary closing conditions, including review under Sweden's Foreign Direct Investment screening legislation.
For more information, please contact:
Karin Granath, CEO, PeptiSystems
Phone: +46 702 82 07 47
Email: karin.granath@peptisystems.com
Ole J. Dahlberg, Managing Partner, Rubicon Healthcare Partners
Email: ole.dahlberg@rubiconhp.com
This information was brought to you by Cision http://news.cision.com.
The following files are available for download:
|
PeptiSystems secures growth equity investment from Rubicon Healthcare Partners to accelerate commercial expansion |
|
|
PeptiSystems-growth-capital-from-Rubbicon-Healthcare-Partners |
View original content:https://www.prnewswire.com/news-releases/peptisystems-secures-growth-equity-investment-from-rubicon-healthcare-partners-to-accelerate-commercial-expansion-302614196.html
SOURCE PeptiSystems AB
Frequently Asked Questions
What does PeptiSystems do?
PeptiSystems develops advanced manufacturing solutions for peptide and oligonucleotide-based therapeutics.
What is Rubicon Healthcare Partners?
Rubicon Healthcare Partners is a growth-oriented investment firm focused on Nordic life science companies.
What will the investment be used for?
The investment will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions.
First published on Thu, Nov 13, 2025
Liked what you read? That’s only the tip of the tech iceberg!
Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!
Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.
Dive into TechDogs' treasure trove today and Know Your World of technology like never before!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending PR Newswire
Dreame Launches Ultimate Roboticmower At CES 2026: All-Terrain, Wire-Free, With Built-In Security
Infosys And AWS Collaborate To Accelerate Enterprise Adoption Of Generative AI
Infosys And Cognition Announce Strategic Collaboration To Accelerate The AI Value Journey For Global Enterprises
Medicus Healthcare Solutions Releases A Comprehensive Report On The United States Physician Shortage
Motorola Brings New Accessories To The Moto Things Franchise At CES 2026
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion